Table 1.

Studies in the literature reporting the interaction of HCAs with CDs.

HCA	Type of CD	References
CA	αCD	[30,33,34,35,36,37,38]
	βCD	[30,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]
	HPβCD	[30,33,34,44,45,50,51,52]
	SBEβCD	[53]
	MβCD	[30,45]
	Crysmeb®	[33,34]
	DIMEB	[54]
	RAMEB	[33,34]
	γCD	[30,36,55,56]
	Polymeric βCD	[57]
CGA	αCD	[31,58]
	βCD	[31,40,42,48,58,59,60,61,62,63,64,65,66,67,68]
	HPβCD	[58,60,66,69]
	MβCD	[58]
	γCD	[31,58]
	Polymeric βCD	[31]
m-COA	αCD	[70,71]
	βCD	[70,71,72]
o-COA	αCD	[70,71]
	βCD	[70,71,72]
p-COA	αCD	[33,34,70,71]
	TRIMEA	[54]
	βCD	[33,34,43,46,47,49,70,71,72]
	HPβCD	[33,34,50,73]
	Crysmeb®	[33,34]
	DIMEB	[54]
	RAMEB	[33,34]
	TRIMEB	[54]
FA	αCD	[33,34,38,74,75,76,77,78]
	TRIMEA	[54]
	βCD	[28,33,34,38,43,46,49,74,77,79,80]
	AminoβCD	[29,74]
	HPβCD	[33,34,73,78,79,81,82,83,84]
	SBEβCD	[53]
	MβCD	[78]
	Crysmeb®	[33,34]
	DIMEB	[54]
	RAMEB	[33,34]
	γCD	[74,77,85]
	HPγCD	[78,84]
	Polymeric βCD	[32]
RA	αCD	[86]
	βCD	[86,87,88,89]
	HEβCD	[86]
	MβCD	[86]
	Crysmeb®	[90]
	HPβCD	[52,86,90]
	γCD	[89]